Benjamin Carpentier

Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study

Srđan Verstovšek, Aaron T. Gerds, Alessandro M. Vannucchi et al. · The Lancet · 2023 · 185 citations

Medicine, Hematology, Pharmacology +9

Increased Risk of Serious Bacterial Infections Due to Maternal Immunosuppression in HIV-Exposed Uninfected Infants in a European Country

Clément Taron-Brocard, Jérôme Le Chenadec, Albert Faye et al. · Clinical Infectious Diseases · 2014 · 87 citations · Full text

Public Health, Infectious Diseases, Maternal Health +17

Efficacy and safety of targeted therapies in VEXAS syndrome: retrospective study from the FRENVEX

Jérôme Hadjadj, Yann Nguyen, Dalila Mouloudj et al. · Annals of the Rheumatic Diseases · 2024 · 64 citations

Medicine, Molecular Genetics, Pharmacology +10

Reduced Venetoclax Exposition to Seven Days of Azacitidine Is Efficient in Treatment-Naïve Patients with Acute Myeloid Leukemia

Christophe Willekens, Samy Chraïbi, Justine Decroocq et al. · Blood · 2022 · 30 citations

Medicine, Pharmacology, Pharmacotherapy +6

Anti-C5 antibody treatment for delayed hemolytic transfusion reactions in sickle cell disease

Aline Floch, Alexandre Morel, Fabian Zanchetta-Balint et al. · Haematologica · 2020 · 29 citations · Full text

Medicine, Hematology, Immunology +14